Compare TDY & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TDY | TEVA |
|---|---|---|
| Founded | 1960 | 1901 |
| Country | United States | Israel |
| Employees | N/A | 32842 |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.1B | 33.5B |
| IPO Year | 2000 | N/A |
| Metric | TDY | TEVA |
|---|---|---|
| Price | $625.82 | $30.06 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 8 |
| Target Price | ★ $656.75 | $37.38 |
| AVG Volume (30 Days) | 258.4K | ★ 6.6M |
| Earning Date | 04-22-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 9.70 | N/A |
| EPS | ★ 18.88 | N/A |
| Revenue | ★ $1,020,400,000.00 | N/A |
| Revenue This Year | $5.50 | N/A |
| Revenue Next Year | $5.07 | $2.51 |
| P/E Ratio | $32.76 | ★ $28.19 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $419.00 | $12.47 |
| 52 Week High | $693.38 | $37.35 |
| Indicator | TDY | TEVA |
|---|---|---|
| Relative Strength Index (RSI) | 47.60 | 47.82 |
| Support Level | $525.76 | $28.38 |
| Resistance Level | $630.76 | $31.99 |
| Average True Range (ATR) | 17.80 | 0.92 |
| MACD | -2.26 | 0.20 |
| Stochastic Oscillator | 62.08 | 76.29 |
Teledyne Technologies Inc provides enabling technologies to sense, analyze and distribute information for industrial growth markets that require advanced technology and high reliability. The firm operates in four segments: Digital Imaging, Instrumentation, Aerospace and Defense Electronics, and Engineered Systems. The Digital Imaging segment, that derives maximum revenue, includes high-performance sensors, cameras and systems, within the visible, infrared and X-ray spectra for use in industrial, government and medical applications, as well as MEMS and high-performance, high-reliability semiconductors including analog-to-digital and digital-to-analog converters. Geographically, the company operates in United States, Europe, Asia, and All other.
Teva Pharmaceutical, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.